Bringing a novel pharmaceutical or medical device to market is a complex journey, governed by strict regulatory oversight. For innovators, understanding the various types of regulatory submissions required at each phase of development is not just about compliance—it’s about strategy. A well-executed submission strategy ensures a smooth, efficient process from pre-clinical testing to post-market surveillance.
Write a comment ...